DB19092InvestigationalVaccines
Modified vaccinia virus Ankara-85A antigen is under investigation in clinical trial NCT00953927 (A Study of MVA85A in Healthy Infants).
- Also known as
- Modified vaccinia virus ankara-mycolyl transferase 85a (mycobacterium tuberculosis h37rv) expressing virus
- Code names
- MVA-85A
Resolves to
Compound
What you can answer from here — as of July 04, 2024
Which companies are running trials of Modified vaccinia virus Ankara-85A antigen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account